Target intelligence / Profile preview

Classically activated macrophage (M1 phenotype) (M1 macrophage)

Target
M1 macrophage
Molecular classification
Other (cellular phenotype; not a single molecule or protein)
01

Overview

The **M1 macrophage** or **classically activated macrophage** refers to a functional state of the innate immune cell known as the macrophage. This phenotype is induced by exposure to interferon-gamma, tumor necrosis factor, and microbial products such as lipopolysaccharide. M1 macrophages are characterized by their high production of pro-inflammatory cytokines—including IL‑6, IL‑12, TNF‑α—and reactive oxygen/nitrogen species. They play key roles in host defense against pathogens through phagocytosis and antigen presentation but can also contribute to tissue damage if their activity is excessive or uncontrolled[1][3][5]. The M1/M2 classification describes cellular states rather than discrete molecular targets; thus “Macrophage M1 phenotype” is not itself a druggable target like a receptor or enzyme[4]. **Note:** “Macrophage M1 phenotype” does *not* refer to a specific molecule or canonical drug target but rather describes one end of the spectrum of functional states that tissue-resident or recruited monocyte-derived cells can adopt in response to environmental cues[4]. Drugs may influence polarization toward this state indirectly via upstream signaling pathways such as TLRs, IFN receptors, NF‑κB pathway modulators etc., but there is no single “M1 receptor” or protein that defines this target for pharmacological intervention. (no direct drugs target the "M1 phenotype" as it is a cell state, but some agents modulate polarization; not applicable; drugs may shift polarization but do not bind to an "M1 receptor")

Other names
M1 phenotypeclassically activated macrophagepro-inflammatory macrophage
02

Biological functions

Immune responseInflammationAntigen presentationPhagocytosis
03

Disease associations

InfectionInflammationCancer (tumor microenvironment modulation)
04

Safety considerations

Excessive activation can lead to tissue damage and cytokine storm
05

Biomarkers

CD80 (B7.1)CD86 (B7.2)CD64 (FcγRI)CD16/CD32 (FcγRIII/FcγRII)Inducible nitric oxide synthase (iNOS/NOS2)

Beyond the preview

Go deeper on Classically activated macrophage (M1 phenotype) (M1 macrophage).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Classically activated macrophage (M1 phenotype) (M1 macrophage).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call